• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.


    July 30, 2020

    Media Contact:

    Deidre McCabe, Director, Office of Communications, 410-767-3536

    Charlie Gischlar, Deputy Director, Media Relations, 443-463-7234 

    Governor Hogan announces new senior leadership for MDH's Public Health Administration

    Dr. Jinlene Chan to replace Deputy Secretary Fran Phillips; four other senior positions announced


    Baltimore, MD – Governor Larry Hogan today announced several key additional appointments to the Maryland Department of Health's (MDH) Public Health Administration (PHA). 

    On Wednesday, the governor announced that Dr. Jinlene Chan will serve as Acting Deputy Secretary for Public Health, succeeding Fran Phillips, who is retiring. Phillips, who has held numerous leadership roles in public health over the years, has played a major role during the COVID-19 pandemic, appearing frequently alongside Governor Hogan at press conferences in Annapolis.

    Dr. Chan, MDH’s Assistant Secretary of Health, has led the state’s COVID-19 Testing Task Force for the past five months, overseeing its expansion from a single testing site to a statewide network of more than 220 sites. As Assistant Secretary of Health, Dr. Chan served as chief medical advisor to the Secretary, oversaw two state chronic hospitals, and led Department initiatives including strategies to address hepatitis C virus and post-acute care needs for complex patients. 

    In addition to Dr. Chan’s appointment as Acting PHA Deputy Secretary, the following public health appointments were announced:


    Dr. Sohail Qarni was appointed Medical Director of the Prevention and Health Promotion Administration (PHPA). In this role, he will develop operational policies, evaluate services, coordinate and analyze data, and make recommendations and decisions to improve clinical service delivery. Dr. Qarni is a Public Health and Board Certified Family Practice physician, and served as Chief of the Communicable Diseases Division at the Baltimore County Health Department. Dr. Qarni previously provided care in private practice and as a medical consultant at the Anne Arundel County Health Department. 

    Dr. Shelly Choo joined MDH as Director of the Maternal and Child Health Bureau (MCHB). Dr. Choo is a Public Health and General Preventive Medicine physician. She previously served as Chief Medical Officer for the Baltimore City Health Department, where she worked on various population and behavioral health initiatives. She also served as Senior Medical Advisor with B'more for Healthy Babies, where she oversaw provider outreach efforts and infant safe sleep initiatives.

    Dr. Jeffrey S. Woolford has been appointed Director of Community and Facility Initiatives. In this role, he will lead all non-regulatory COVID-19 matters involving nursing homes, assisted living facilities, group homes and other congregate living settings. Dr. Woolford has more than 30 years of leadership experience. He received his MD from the Uniformed Services University of the Health Sciences and is Board Certified in preventive and aerospace medicine. He comes to MDH from the Maryland Department of Human Services, where he served as Chief of Staff. He currently serves as the Maryland Air National Guard Deputy State Air Surgeon.


    Dr. Katherine Feldman joined MDH as Chief Public Health Scientist. In this role, she will provide subject matter expertise for COVID-19 and infectious disease surveillance, investigation and response and support COVID-19 response and recovery strategies. Dr. Feldman brings significant public health leadership, pandemic response experience, and quantitative, analytical and executive skills to lead these efforts. Having previously served as MDH’s State Public Health Veterinarian, she has returned to MDH after nearly three years with the MITRE Corporation.



    The Maryland Department of Health is dedicated to protecting and improving the health and safety of all Marylanders through disease prevention, access to care, quality management and community engagement.

    Follow us on Twitter @MDHealthDept and at Facebook.com/MDHealthDept